+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endometriosis Global Clinical Trials Review, H1, 2019

  • ID: 4791376
  • Clinical Trials
  • Region: Global
  • 267 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Allergan Plc
  • Astellas Pharma Inc
  • Bayer AG
  • Ferring Holding SA
  • Ipsen SA
  • MORE
Endometriosis Global Clinical Trials Review, H1, 2019

Summary

This clinical trial report, “Endometriosis Global Clinical Trials Review, H1, 2019" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). This Clinical Trial Reports are generated using the publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Allergan Plc
  • Astellas Pharma Inc
  • Bayer AG
  • Ferring Holding SA
  • Ipsen SA
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Endometriosis Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Endometriosis
May 09, 2019: ObsEva announces initiation of phase 3 EDELWEISS 2 and 3 trials of Linzagolix for endometriosis associated pain in U.S., Canada and Europe
May 03, 2019: ObsEva reports consistent long-term findings from phase 2b EDELWEISS trial of Linzagolix for endometriosis-associated pain
Mar 21, 2019: Valirx provides update on its endometriosis drug candidate VAL301 development progress
Mar 07, 2019: Forendo Pharma: Positive phase 1a results of FOR-6219
Feb 28, 2019: Evotec receives milestone payment for start of second Phase II trial in its multi-target alliance with Bayer
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About the Publisher
Contact Us
Disclaimer
Source

List of Tables
Endometriosis Therapeutics, Global, Clinical Trials by Region, 2019*
Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
Endometriosis Therapeutics Clinical Trials, North America, Top Countries, 2019*
Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
Endometriosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2019*
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2019*
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Endometriosis Therapeutics, Global, Clinical Trials by Phase, 2019*
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures
Endometriosis Therapeutics, Global, Clinical Trials by Region (%), 2019*
Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
Endometriosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
Endometriosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2019*
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2019*
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Endometriosis Therapeutics, Global, Clinical Trials by Phase (%), 2019*
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc
  • Bayer AG
  • Neurocrine Biosciences Inc
  • Ferring Holding SA
  • Allergan Plc
  • Takeda Pharmaceutical Co Ltd
  • Pfizer Inc
  • Astellas Pharma Inc
  • Mochida Pharmaceutical Co Ltd
  • Ipsen SA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4791376
Adroll
adroll